Financials Delivra Health Brands Inc.

Equities

DHB

CA24703H1029

Pharmaceuticals

Market Closed - Toronto S.E. 03:29:40 2024-07-12 pm EDT 5-day change 1st Jan Change
0.03 CAD 0.00% Intraday chart for Delivra Health Brands Inc. 0.00% +50.00%

Valuation

Fiscal Period: June 2019 2022 2023 2024 2025
Capitalization 1 133.8 7.579 2.526 9.379 -
Enterprise Value (EV) 1 133.8 7.579 2.526 9.379 9.379
P/E ratio - -1 x - -30 x -
Yield - - - - -
Capitalization / Revenue 11.7 x - 0.26 x 0.75 x 0.67 x
EV / Revenue 11.7 x - 0.26 x 0.75 x 0.67 x
EV / EBITDA -8.96 x - 4.89 x 7.4 x 5.48 x
EV / FCF - - - 17.7 x 7.47 x
FCF Yield - - - 5.65% 13.4%
Price to Book - - - - -
Nbr of stocks (in thousands) 185,820 252,618 252,618 312,618 -
Reference price 2 0.7200 0.0300 0.0100 0.0300 0.0300
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2022 2023 2024 2025
Net sales 1 11.46 - 9.791 12.44 13.93
EBITDA 1 -14.94 - 0.517 1.268 1.711
EBIT 1 - - -0.813 -0.082 0.334
Operating Margin - - -8.3% -0.66% 2.4%
Earnings before Tax (EBT) 1 - - - -0.454 0.034
Net income 1 - -7.009 - -0.454 0.031
Net margin - - - -3.65% 0.22%
EPS 2 - -0.0300 - -0.001000 -
Free Cash Flow 1 - - - 0.53 1.255
FCF margin - - - 4.26% 9.01%
FCF Conversion (EBITDA) - - - 41.8% 73.35%
FCF Conversion (Net income) - - - - 4,048.39%
Dividend per Share - - - - -
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 Q3
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -0.685
Net margin -
EPS 2 -0.003000
Dividend per Share -
Announcement Date 5/23/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - - - 0.53 1.26
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - - - 0.1 0.1
Capex / Sales - - - 0.8% 0.72%
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.03 CAD
Average target price
0.08 CAD
Spread / Average Target
+166.67%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DHB Stock
  4. Financials Delivra Health Brands Inc.